John C. Roche - 28 Mar 2025 Form 4 Insider Report for HANOVER INSURANCE GROUP, INC. (THG)

Role
President and CEO, Director
Signature
/s/ Lindsay L. Katz pursuant to Confirming Statement
Issuer symbol
THG
Transactions as of
28 Mar 2025
Net transactions value
-$68,072
Form type
4
Filing time
01 Apr 2025, 16:06:51 UTC
Previous filing
28 Mar 2025
Next filing
02 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THG Common Stock Options Exercise $31,164 +400 +0.32% $77.91 124,678 28 Mar 2025 Direct F1, F2
transaction THG Common Stock Sale $70,012 -400 -0.32% $175.03 124,278 28 Mar 2025 Direct F1, F2
transaction THG Common Stock Award $0 +136 +0.11% $0.000000 124,414 28 Mar 2025 Direct F2, F3
transaction THG Common Stock Options Exercise $23,451 +301 +0.24% $77.91 124,715 31 Mar 2025 Direct F1, F2
transaction THG Common Stock Sale $52,675 -301 -0.24% $175.00 124,414 31 Mar 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THG Common Stock Option (right to buy) Options Exercise $0 -400 -4.2% $0.000000 9,207 28 Mar 2025 Common Stock 400 $77.91 Direct F1, F4
transaction THG Common Stock Option (right to buy) Options Exercise $0 -301 -3.3% $0.000000 8,906 31 Mar 2025 Common Stock 301 $77.91 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Exercise of options scheduled to expire in February 2026 and resulting sale of shares reported were effected pursuant to a pre-established Rule 10b5-1 Trading Plan adopted on November 5, 2024.
F2 Does not include 14,454 shares held by the Reporting Person's spouse.
F3 Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.
F4 The option, representing the right to purchase a total of 21,413 shares, vested 1/3 on each of 2/23/17, 2/23/18 and 2/23/19.